PRA Health Sciences
Contract Research Organization
Contract Research Organization
  • Founded: 1976
  • CEO: Colin Shannon
  • Size of Facility: ?
  • Company Size: ?
  • Funding Source: Publicly Traded
  • Development Stage: On the market, Phase 1-2 Clinical Trials, Phase 3 Clinical Trial

PRA provides clinical services for all phases of biopharmaceutical drug development. We have the depth of therapeutic expertise and operational diversity to offer high-quality, full-service support as well as embedded staffing solutions. Staff at PRA are committed to provide innovative solutions that clients rely upon to introduce new drugs and to improve lives.